Reporting- Foreign Establishments Response to Questions By FDA Regarding Products Offered for Import into The U.S. Response is Communicated on Behalf of Foreign Establishments United States Agent

Implementation of Sections 222, 223 and 224 of the Food and Drug Administration Act of 2007

OMB: 0910-0625

IC ID: 193011

Information Collection (IC) Details

View Information Collection (IC)

Reporting- Foreign Establishments Response to Questions By FDA Regarding Products Offered for Import into The U.S. Response is Communicated on Behalf of Foreign Establishments United States Agent
 
No New
 
Mandatory
 
21 CFR 807.40 (b)(2)

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Form and Instruction 3673 Device Registration & Listing Module Form FDA 3673 Device Regs & Liasting Module.doc Yes Yes Fillable Fileable

Health Consumer Health and Safety

 

50 0
   
Private Sector Businesses or other for-profits
 
   99 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 50 50 0 0 0 0
Annual IC Time Burden (Hours) 25 25 0 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy